VOCs in Patients With Acute Cardiogenic Chest Pain

Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Feb 18, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how certain breath markers, known as Volatile Organic Compounds (VOCs), can help identify patients experiencing acute chest pain due to heart problems. The researchers want to find out if measuring these VOCs can lead to quicker and better emergency care for people with acute coronary syndrome or acute aortic syndrome. They will compare VOC levels in patients with chest pain to those in healthy individuals to see if there are specific markers that can predict heart issues and their outcomes.

To participate, you need to be at least 18 years old and may qualify if you have acute chest pain or if you are healthy without any serious underlying conditions. Participants will provide breath samples, and the study aims to gather information that could improve emergency detection methods for heart-related problems. If you join, you'll be contributing to important research that could help many patients in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Observation group inclusion criteria:
• • 1. Over 18 years old, male or female;
• • 2. Patients with acute cardiogenic chest pain (see diagnostic criteria);
• • 3. Patient\'s informed consent.
• Inclusion criteria of healthy control group:
• • 1. Over 18 years old, male or female;
• • 2. Centerless cerebrovascular disease, lung disease, no abnormal liver and kidney function, no acute infection recently;
• • 3. Informed consent.
• Exclusion Criteria:
• • 1. The patient had difficulty in collecting breath;
• • 2. Patients with terminal illness or receiving palliative care;
• • 3. Have participated in other clinical studies or consider it inappropriate to participate in this study.